Bukwang Pharmaceutical Co. Ltd.
South Korean pharma leader Bukwang produces oral solids, injectables and nutraceuticals. With a robust domestic market, its pipeline features Lurasidone for schizophrenia, JM‑010 for Parkinson’s dyskinesia and SOL‑804 for metastatic prostate cancer, driving global expansion.
Headquarters: South Korea (KOR)
- Website: Visit Site 🔗
- Type: Corporation
Company Profile
- Sector: Manufacturing
- Industry: Pharmaceutical Manufacturing
- HQ: Seoul
Unlock the full potential.
Upgrade
Get access to Relative P/E Ratio Valuation Histogram.